tiprankstipranks
AstraZeneca reports Q1 core EPS $2.06, consensus $1.22
PremiumThe FlyAstraZeneca reports Q1 core EPS $2.06, consensus $1.22
4d ago
AZN Earnings: AstraZeneca Soars on Impressive Q1 Results
PremiumMarket News
AZN Earnings: AstraZeneca Soars on Impressive Q1 Results
4d ago
AstraZeneca put volume heavy and directionally bearish
PremiumThe Fly
AstraZeneca put volume heavy and directionally bearish
5d ago
AstraZeneca upgraded to Hold from Sell at Deutsche Bank (earlier)
PremiumThe FlyAstraZeneca upgraded to Hold from Sell at Deutsche Bank (earlier)
12d ago
AstraZeneca: Imfinzi + chemo doubled OS at  three years for patients with BTC
PremiumThe Fly
AstraZeneca: Imfinzi + chemo doubled OS at three years for patients with BTC
12d ago
AstraZeneca reports updated exploratory results from TOPAZ-1 Phase 3 trial
PremiumThe Fly
AstraZeneca reports updated exploratory results from TOPAZ-1 Phase 3 trial
12d ago
Roche announces CE Mark for Ventana HER2 Rabbit Monoclonal Primary RxDx
PremiumThe FlyRoche announces CE Mark for Ventana HER2 Rabbit Monoclonal Primary RxDx
19d ago
ZTS, EXAS, AZN: Which Biotech Stock Is the Better Buy?
PremiumStock Analysis & Ideas
ZTS, EXAS, AZN: Which Biotech Stock Is the Better Buy?
19d ago
Nuvectis says NXP900 demonstrates robust activity in NSCLC
PremiumThe Fly
Nuvectis says NXP900 demonstrates robust activity in NSCLC
20d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100